We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$469M
AUM Growth
-$155M
Cap. Flow
-$70.4M
Cap. Flow %
-15.02%
Top 10 Hldgs %
55.66%
Holding
40
New
3
Increased
12
Reduced
16
Closed
9

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$12.8M
2
CVS icon
CVS Health
CVS
+$8.07M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.28M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.57M
5
LIVN icon
LivaNova
LIVN
+$4.62M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$17.6M
2
ABT icon
Abbott
ABT
+$16.3M
3
GILD icon
Gilead Sciences
GILD
+$14.9M
4
QGEN icon
Qiagen
QGEN
+$14.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$123B
$37.8M 8.05%
677,433
-288,000
-30% -$17.6M
INCY icon
2
Incyte
INCY
$23.1B
$33.1M 7.07%
452,583
+170,041
+60% +$12.8M
BSX icon
3
Boston Scientific
BSX
$65.1B
$31.7M 6.76%
970,982
-66,041
-6% -$2.58M
ABT icon
4
Abbott
ABT
$177B
$29.2M 6.23%
370,334
-195,663
-35% -$16.3M
MRK icon
5
Merck
MRK
$307B
$28.7M 6.11%
390,584
+18,759
+5% +$1.47M
BIIB icon
6
Biogen
BIIB
$29.5B
$23.8M 5.07%
75,120
-27,099
-27% -$8.22M
RVTY icon
7
Revvity
RVTY
$11.9B
$21M 4.47%
278,522
-29,577
-10% -$2.63M
ELV icon
8
Elevance Health
ELV
$82.9B
$20.3M 4.34%
89,602
+13,094
+17% +$3.57M
A icon
9
Agilent Technologies
A
$36.8B
$18.4M 3.92%
256,716
-21,711
-8% -$1.74M
PRGO icon
10
Perrigo
PRGO
$1.47B
$17.1M 3.65%
356,240
+83,596
+31% +$4.48M
NUVA
11
DELISTED
NuVasive, Inc.
NUVA
$15.9M 3.4%
314,828
-72,752
-19% -$4.88M
UTHR icon
12
United Therapeutics
UTHR
$22.5B
$15.4M 3.29%
162,554
+11,939
+8% +$1.13M
JNJ icon
13
Johnson & Johnson
JNJ
$599B
$15.4M 3.29%
117,532
+303
+0.3% +$43K
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$15.1M 3.23%
168,503
+42,339
+34% +$4.16M
GILD icon
15
Gilead Sciences
GILD
$165B
$14.9M 3.18%
199,419
-216,186
-52% -$14.9M
HUM icon
16
Humana
HUM
$47.8B
$14M 2.99%
44,657
-604
-1% -$204K
IONS icon
17
Ionis Pharmaceuticals
IONS
$8.75B
$13M 2.78%
275,481
+57,846
+27% +$3.22M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.4B
$11.8M 2.51%
139,582
+64,679
+86% +$5.57M
BRKR icon
19
Bruker
BRKR
$8.55B
$11.7M 2.5%
326,846
-14,904
-4% -$691K
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.08B
$11.4M 2.43%
32,470
-12,400
-28% -$4.56M
ELAN icon
21
Elanco Animal Health
ELAN
$12.6B
$11.2M 2.4%
501,762
+68,285
+16% +$1.87M
CAH icon
22
Cardinal Health
CAH
$52.9B
$9.98M 2.13%
208,192
-4,371
-2% -$227K
DGX icon
23
Quest Diagnostics
DGX
$23B
$9.08M 1.94%
113,042
+36,066
+47% +$3.73M
PDCO
24
DELISTED
Patterson Companies, Inc.
PDCO
$8.11M 1.73%
530,217
+52,862
+11% +$1.14M
CVS icon
25
CVS Health
CVS
$137B
$7.17M 1.53%
+120,860
New +$8.07M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2020 Portfolio in Review

As of Q1 2020, Sector Gamma AS held 40 positions worth $469M, down 25% from $624M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sector Gamma AS withdrew a net $70.4M in Q1 2020, closing 9 positions and reducing 16 holdings. Its most notable exit was Qiagen, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in CVS Health worth $7.17M.

  • Sector Gamma AS's largest Q1 2020 buy was CVS Health: 120,860 shares worth $7.17M.
  • Sector Gamma AS added most to Incyte in Q1 2020, an estimated $12.8M increase.
  • Sector Gamma AS's biggest Q1 2020 reduction was Bristol-Myers Squibb, cutting an estimated $17.6M.
  • Sector Gamma AS fully exited Qiagen in Q1 2020, selling an estimated $14.7M.
  • Sector Gamma AS's ten largest holdings make up 56% of its $469M portfolio in Q1 2020.
  • Sector Gamma AS opened 3 new positions and closed 9 in Q1 2020.
  • Sector Gamma AS's portfolio value fell 25% quarter-over-quarter to $469M.

Based on Sector Gamma AS's 13F filing for Q1 2020, filed 11 May 2020.